Hypogammaglobulinemia and infection risk in solid organ transplant recipients

Current Opinion in Organ Transplantation

Volumn 13, Issue 6, 2008, Pages 581-585

  Mawhorter, Steven ^a   Yamani, Mohamad H ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Hypogammaglobulinemia; Infection; Organ transplantation

Indexed keywords

CORTICOSTEROID; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; STEROID; THYMOCYTE ANTIBODY; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR;

ACUTE GRAFT REJECTION; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; IMMUNOTHERAPY; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; NONHUMAN; OPPORTUNISTIC INFECTION; PATIENT MONITORING; POSTOPERATIVE INFECTION; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; VIRUS INFECTION; AGAMMAGLOBULINEMIA; ANIMAL; BLOOD; COMMUNICABLE DISEASE; ORGAN TRANSPLANTATION; RISK ASSESSMENT;

AGAMMAGLOBULINEMIA; ANIMALS; COMMUNICABLE DISEASES; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; RISK ASSESSMENT;

EID: 60849106395     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283186bbc     Document Type: Review

References (32)

1. Rose ME, Lang DM. Evaluating and managing hypogammaglobulinemia. Cleveland Clinic J Med 2006; 73:133-144.
2. Thaler SJ, Rubin RH. Opportunistic infections in the cardiac transplant patient. Curr Opin Cardiol 1996; 11:191-203.
3. Smart FW, Naftel DC, Costanzo MR, et al. Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1996; 15:329-341.
4. Corales R, Chua J, Mawhorter SD, et al. Significant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon? Transplant Infect Dis 2000; 2:133-139.
5. Goldfarb NS, Avery RK, Goormastic M, et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001; 71:242-246.
6. Yamani MH, Avery RK, Mawhorter S, et al. Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection. J Heart Lung Transplant 2001; 20:425-431.
7. Carpenter CB. Immunosuppression in organ transplantation. N Engl J Med 1990; 322:1224-1226.
8. Kobashigawa JA. Mycophenolate mofetil in cardiac transplantation. Curr Opin Cardiol 1998; 13:117-121.
9. Mathiesen T, Brattstrom J, Anderson A, et al. Immunoglobulin G subclasses and lymphocyte responses to cytomegalovirus in transplant patients with cytomegalovirus infections. J Med Virol 1992; 36:65-69.
10. Rosenberg YT, Chiller JM. Ability of antigen-specific helper cells to effect a class-restricted increase in total Ig-secreting cells in spleen after immunization with the antigen. J Exp Med 1979; 150:517-530.
11. Wieneke H, Otte B, Lang D, Heidenreich S. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Clin Nephrol 1996; 45:22-28.
12. Kroemer G, Martinez AC. Pharmacological inhibition of programmed cell death. Immunol Today 1994; 15:235-242.
13. Sackstein R, Borenstein M. The effects of corticosteroids on lymphocyte recirculation in humans: analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration. J Invest Med 1995; 43:68-77.
14. Kelso A, Munk A. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones. J Immunol 1984; 133:784-791.
15. Yamani MH, Avery R, Mawhorter S, et al. Hypogammaglobulinemia after heart transplantation: impact of preemptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes. Transplant Infectious Disease 2001; 3 (Suppl2):40-43.
16. Munoz P, Giannella M, Alcala L, et al. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer? J Heart Lung Transplant 2007; 26:907-914.
17. Sarmiento E, Fernandez-Yanez J, Munoz P, et al. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease. Int Immunopharmacol 2005; 5:97-101.
18. Carbone J, Sarmiento E, Palomo J, et al. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections. Transplant Proc 2007; 39:2385-2388.
19. Yamani MH, Avery R, MawhorterSD, et al. The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study. J Heart Lung Transplant 2005; 24:1766-1769.
20. Kawut SM, Shah L, Wilt JS, et al. Risk factors and outcomes of hypogammaglobulinemia after lung transplantation. Transplantation 2005; 79:1723-1726.
21. Yip NH, Lederer DJ, Kawut SM, et al. Immunoglobulin G levels before and after lung transplantation. Am J Respir Crit Care Med 2006; 173: 91 7-921.
22. Keven K, Sahin M, KutlayS, et al. Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine. Transpl Infect Dis 2003; 5:181-186.
23. Miller BW, Brennan DC, Korenblatt PE, et al. Common variable immunodeficiency in a renal transplant patient with severe recurrent bacterial infection: case report and review of the literature. Am J Kidney Dis 1995; 25:947-951.
24. Duma RJ. Unusual infections in transplant patients. Transplant Proc 1972; 4:711-715.
25. Anderson RJ, Schafer LA, Olin DB, Eickhoff TC. Infectious risk factors in the immunosuppressed host. Am J Med 1973; 54:453-460.
26. Pollock CA, Mahony JF, Ibels LS, et al. Abnormal serum gamma globulin concentrations in renal transplant patients. Transplant Proc 1989; 1:3215-3216.
27. Braun WE, Avery R, Gifford RW Jr, Straffon RA. Life after 20 years with a kidney transplant: redefined disease profiles and an emerging nondiabetic vasculopathy. Transplant Proc 1997; 29:247-249.
28. Broeders EN, Wissing KM, Ghisdal L, et al. Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: association with infectious complications. Transpl Int 2008; 21:57-64.
29. Darabi K, Abdel-Wahab O, Dzik WH. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion 2006; 46:741-753.
30. Casadei DH, del C Rial M, Opelz G, et al. A randomized and prospective study comparing treatment with high-dose IVIG with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2001; 71:53-58.
31. Van Thiel DH, Finkel R, Friedlander L, et al. The association of IgA deficiency but not IgG or IgM deficiency with a reduced patient and graft survival following liver transplantation. Transplantation 1992; 54:269-273.
32. Doron S, Ruthazer R, Werner BG, et al. Hypogammaglobulinemia in liver transplant recipients: incidence, timing, risk factors, and outcomes. Transplantation 2006; 81:697-703.